- Home
- ACDC vs SEPN Comparison
ACDC vs SEPN Comparison
Compare ACDC & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACDC
- SEPN
- Stock Information
- Founded
- ACDC 2014
- SEPN 2022
- Country
- ACDC United States
- SEPN United States
- Employees
- ACDC N/A
- SEPN N/A
- Industry
- ACDC Oilfield Services/Equipment
- SEPN
- Sector
- ACDC Energy
- SEPN
- Exchange
- ACDC Nasdaq
- SEPN NYSE
- Market Cap
- ACDC 1.1B
- SEPN 453.2M
- IPO Year
- ACDC 2022
- SEPN 2024
- Fundamental
- Price
- ACDC $7.79
- SEPN $11.67
- Analyst Decision
- ACDC Sell
- SEPN Strong Buy
- Analyst Count
- ACDC 4
- SEPN 5
- Target Price
- ACDC $6.50
- SEPN $26.75
- AVG Volume (30 Days)
- ACDC 776.8K
- SEPN 434.7K
- Earning Date
- ACDC 08-07-2025
- SEPN 08-15-2025
- Dividend Yield
- ACDC N/A
- SEPN N/A
- EPS Growth
- ACDC N/A
- SEPN N/A
- EPS
- ACDC N/A
- SEPN N/A
- Revenue
- ACDC $2,209,700,000.00
- SEPN $977,000.00
- Revenue This Year
- ACDC N/A
- SEPN $3,429.67
- Revenue Next Year
- ACDC $0.38
- SEPN N/A
- P/E Ratio
- ACDC N/A
- SEPN N/A
- Revenue Growth
- ACDC N/A
- SEPN 108.76
- 52 Week Low
- ACDC $3.83
- SEPN $4.17
- 52 Week High
- ACDC $10.70
- SEPN $28.99
- Technical
- Relative Strength Index (RSI)
- ACDC 48.15
- SEPN N/A
- Support Level
- ACDC $7.58
- SEPN N/A
- Resistance Level
- ACDC $8.31
- SEPN N/A
- Average True Range (ATR)
- ACDC 0.62
- SEPN 0.00
- MACD
- ACDC -0.09
- SEPN 0.00
- Stochastic Oscillator
- ACDC 47.76
- SEPN 0.00
About ACDC ProFrac Holding Corp.
ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. Its operations are focused in West Texas, East Texas/Louisiana, South Texas, Oklahoma, Uinta, and Appalachian. The company operates in three segments: Stimulation Services, Proppant Production, and Manufacturing. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.